Simultaneous inhibition of mTOR and treatment of human breast cancer specimens with tamoxifen led to stemness reduction, promotion of mesenchymal to epithelial transition (MET), and sensitivity to chemotherapeutic agents.62 This evidence concerns the gene MTOR and breast cancer.